206 related articles for article (PubMed ID: 36515231)
1. The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
Miyakuni S; Maeda D; Matsue Y; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Matsumura A; Minamino T
J Am Heart Assoc; 2022 Dec; 11(24):e025803. PubMed ID: 36515231
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
Nabeta T; Kitai T; Naruse Y; Taniguchi T; Yoshioka K; Tanaka H; Okumura T; Sato S; Baba Y; Kida K; Tamaki Y; Matsumoto S; Matsue Y
Eur Heart J; 2022 Sep; 43(36):3450-3459. PubMed ID: 35781334
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
[TBL] [Abstract][Full Text] [Related]
4. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
[TBL] [Abstract][Full Text] [Related]
5. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
7. Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy.
Nakasuka K; Ishibashi K; Hattori Y; Mori K; Nakajima K; Nagayama T; Kamakura T; Wada M; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Takaya Y; Isobe M; Terasaki F; Ohte N; Kusano K
Heart Rhythm; 2022 Jul; 19(7):1133-1140. PubMed ID: 35257978
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
Iso T; Maeda D; Matsue Y; Dotare T; Sunayama T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Heart; 2023 Aug; 109(18):1387-1393. PubMed ID: 37185298
[TBL] [Abstract][Full Text] [Related]
9. A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis.
Kiko T; Yoshihisa A; Kanno Y; Yokokawa T; Abe S; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Ishida T; Takeishi Y
Int Heart J; 2018 Sep; 59(5):996-1001. PubMed ID: 30101857
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis.
Fujimoto Y; Matsue Y; Maeda D; Dotare T; Sunayama T; Iso T; Nakamura Y; Singh YS; Akama Y; Yoshioka K; Kitai T; Naruse Y; Taniguchi T; Tanaka H; Okumura T; Baba Y; Nabeta T; Minamino T
Eur Heart J Open; 2023 Sep; 3(5):oead100. PubMed ID: 37849788
[TBL] [Abstract][Full Text] [Related]
11. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
12. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
Nordenswan HK; Lehtonen J; Ekström K; Räisänen-Sokolowski A; Mäyränpää MI; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
J Am Heart Assoc; 2021 Mar; 10(6):e019415. PubMed ID: 33660520
[TBL] [Abstract][Full Text] [Related]
13. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure.
Tamura K; Takahashi N; Nakatani Y; Onishi S; Iwasaka T
Gerontology; 2001; 47(1):46-51. PubMed ID: 11244291
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R
Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
Kitada S; Kikuchi S; Tsujino T; Masuyama T; Ohte N;
ESC Heart Fail; 2018 Feb; 5(1):36-45. PubMed ID: 28941144
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
[TBL] [Abstract][Full Text] [Related]
18. Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study.
Matsumura T; Hashimoto H; Sekimizu M; Saito AM; Motoyoshi Y; Nakamura A; Kuru S; Fukudome T; Segawa K; Takahashi T; Tamura T; Komori T; Watanabe C; Asakura M; Kimura K; Iwata Y
Orphanet J Rare Dis; 2022 May; 17(1):201. PubMed ID: 35578298
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
Karmpaliotis D; Kirtane AJ; Ruisi CP; Polonsky T; Malhotra A; Talmor D; Kosmidou I; Jarolim P; de Lemos JA; Sabatine MS; Gibson CM; Morrow D
Chest; 2007 Apr; 131(4):964-71. PubMed ID: 17426196
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
